Loading...
Advances in antitumor effects of NSAIDs
Zhang, Z. Chen, F. Shang, Lijun
Zhang, Z.
Chen, F.
Shang, Lijun
Publication Date
2018-10-15
End of Embargo
Supervisor
Keywords
Rights
© 2018 Zhang et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work
you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2018-07-13
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
In recent years, the reports on using nonsteroidal anti-inflammatory drugs (NSAIDs)
for cancer prevention and treatment have been on the rise. In 2017, the US Preventive Services
Working Group issued primary prevention guidelines on the use of NSAIDs, especially aspirin,
for cardiovascular disease and colorectal cancer, and formally established the role and status of
aspirin in cancer prevention. However, the mechanism of NSAIDs on preventing cancer is still
not clear. In this paper, the progress of the application of NSAIDs, especially aspirin, in the
prevention and treatment of tumors in recent years is summarized, and new ideas and directions
for the follow-up study are also discussed.
Version
Published version
Citation
Zhang Z, Chen F and Shang L (2018) Advances in antitumor effects of NSAIDs. Cancer Management and Research. 10: 4631-4640.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article